(Total Views: 650)
Posted On: 11/09/2021 6:30:41 PM
Post# of 86641
I already addressed this but here it is again. If you look at the last quarter filed before Univec, Inc. went legally dark, look at the footnotes. Dr. Dalton's private company HRI, loaned Univec, Inc. $874,000 (if I remember correctly), and then you look at the 2019 annual on OTC Markets and there is no $874,000 loan to Dr. Dalton, only his DEFERRED compensation. Note Doc never took a penny from Univec, Inc. that I can find.
So, no $874,000 debt to HRI but also there is no revenue from a syringe business or the PPSI business.
So, the logical deduction is simple. Dr. Dalton took out the syringe business and the PPSI business in payment for the loan of $874,000 from his private HRI business. Nothing wrong with that, Univec owed the debt and just like a bank, Doc took the assets for payment. Our benefit is Doc grew them privately and now is ready to move them back into Univec, Inc.
Dr. Dalton wanted to grow everything outside of the prying eyes of the competition, smart man. Those two companies are just two of 5, 6 or maybe more companies to be rolled up into Univec, Inc.
So, no $874,000 debt to HRI but also there is no revenue from a syringe business or the PPSI business.
So, the logical deduction is simple. Dr. Dalton took out the syringe business and the PPSI business in payment for the loan of $874,000 from his private HRI business. Nothing wrong with that, Univec owed the debt and just like a bank, Doc took the assets for payment. Our benefit is Doc grew them privately and now is ready to move them back into Univec, Inc.
Dr. Dalton wanted to grow everything outside of the prying eyes of the competition, smart man. Those two companies are just two of 5, 6 or maybe more companies to be rolled up into Univec, Inc.


Scroll down for more posts ▼